The use of everolimus in renal-transplant patients

The use of everolimus in renal-transplant patients

Julio PascualServicio de Nefrolog&iacute;a, Hospital Ram&oacute;n y Cajal, 28034 Madrid, SpainAbstract: Despite advances in immunosuppressive therapy, long-term renal-transplantation outcomes have not significantly improved over the last decade. The nephrotoxicity of calcineurin inhi...

Full description

Bibliographic Details
Main Author:	Julio Pascual
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-06-01
Series:	International Journal of Nephrology and Renovascular Disease
Online Access:	http://www.dovepress.com/the-use-of-everolimus-in-renal-transplant-patients-a3224

Similar Items

EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
by: E. I. Prokopenko
Published: (2010-06-01)

P-102 EVEROLIMUS IN RENAL DYSFUNCTION IN LIVER TRANSPLANTATION
by: Carolina Salinas, et al.
Published: (2021-09-01)

Critical appraisal on the use of everolimus in renal transplantation as an immunosuppressant to prevent organ transplant rejection
by: Fernando Giron, et al.
Published: (2010-01-01)

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015-06-01)

Everolimus in kidney transplantation
by: Cooper JE, et al.
Published: (2011-07-01)

Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation
by: Helio Tedesco-Silva Jr, et al.
Published: (2011-01-01)

The role of everolimus in liver transplantation
by: Ganschow R, et al.
Published: (2014-09-01)

Everolimus in Heart Transplantation: An Update
by: Stephan W. Hirt, et al.
Published: (2013-01-01)

Everolimus and papillomavirus lesions in female renal transplant recipient: A case report
by: T. Simundic, et al.
Published: (2018-08-01)

Long-term outcome of everolimus treatment in transplant patients
by: Salvadori M, et al.
Published: (2011-05-01)

The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

The Role of Everolimus in Renal Cell Carcinoma
by: Malek Meskawi, et al.
Published: (2015-12-01)

EVEROLIMUS IN THE TREATMENT FOR METASTATIC RENAL CANCER
by: B. Ya. Alekseyev, et al.
Published: (2014-07-01)

EVEROLIMUS IN THE TREATMENT FOR METASTATIC RENAL CANCER
by: B. Ya. Alekseyev, et al.
Published: (2014-07-01)

Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus
by: Lucía Ordóñez-Fernández, et al.
Published: (2019-03-01)

Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients
by: Chow KM, et al.
Published: (2015-05-01)

Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial
by: Zakiyah Kadry, MD, et al.
Published: (2021-07-01)

THE USE OF EVEROLIMUS IN KIDNEY TRANSPLANTATION FROM EXPANDED CRITERIA DONORS
by: I. V. Ulyankina, et al.
Published: (2009-06-01)

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/− Mice Is Superior to Everolimus Alone
by: Jian Yang, et al.
Published: (2017-02-01)

Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma
by: Gang Guo, et al.
Published: (2021-01-01)

Efficacy of everolimus in tuberous sclerosis with renal angiomyolipoma
by: S.H. Choi, et al.
Published: (2020-07-01)

Role of everolimus in the treatment of renal cell carcinoma
by: Saby George, et al.
Published: (2009-08-01)

Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient
by: Serena Patel, et al.
Published: (2018-01-01)

Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients.
by: Lena Caroline Brunkhorst, et al.
Published: (2015-01-01)

FIRST EXPERIENCE IN SYSTEMIC ADMINISTRATION OF EVEROLIMUS IN RENAL TRANSPLANTATION FROM EXPANDED CRITERIA DONORS IN RUSSIAN FEDERATION
by: I. V. Uliyankina, et al.
Published: (2017-01-01)

EVEROLIMUS FOR KAPOSI'S SARCOMA TREATMENT AFTER KIDNEY TRANSPLANTATION
by: I. V. Alexandrov, et al.
Published: (2015-05-01)

Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantation
by: Ramy M Hanna, et al.
Published: (2019-01-01)

Everolimus with low-dose cyclosporine in de novo renal transplant recipients: A single center Indian experience
by: Sailaja Kesiraju, et al.
Published: (2015-01-01)

Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus
by: Tan X, et al.
Published: (2015-01-01)

MOLECULAR MARKERS ASSOCIATED WITH THE RESPONSE TO THERAPY WITH EVEROLIMUS IN PATIENTS WITH RENAL CELL CARCINOMA
by: Z. А. Yurmazov, et al.
Published: (2016-07-01)

Severe Hypertriglyceridemia Associated With Everolimus Treatment After Heart Transplantation
by: Phillip Lo, MD, MMed, et al.
Published: (2020-09-01)

Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma
by: Leonetti A, et al.
Published: (2017-06-01)

Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes
by: Filippo Patrucco, et al.
Published: (2021-02-01)

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
by: Sabrina Rossetti, et al.
Published: (2017-07-01)

Protective effect of everolimus on renal ischemia reperfusion injury in rats
by: Tamer Sagiroglu, et al.
Published: (2014-01-01)

Efficiency and safety of the everolimus in patients with the generalized renal cell carcinoma (multicentral observational study)
by: M. I. Volkova, et al.
Published: (2016-06-01)

Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01)

Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma
by: Chung-Han Lee, et al.
Published: (2021-09-01)